Equity Field Notes from temporal sources

[DanWebzster]

PRPL

SPAC-conversion aimed primarily at young mattress buyers

Revs grew from ~66mn in 2016 to ~192mn in 2017

Revs will likely exceed 370mn in 2018 and may turn EBITDA positive

holds 78 patents for Hyper Elastic Polymer

If they acheive 1 % market share they will have 1bn+ in Revs

Mattress Firm will market PRPL products and no longer market Tempur Sealy

May expand into insoles & seat cushions

Cautions:

* AMZN pushing low cost Chinese mattresses
* AMZN reviews for PRPL product not good
( The world would be a better place w/o american oligarch Bezos)


Will report Q4 earnings in first 2 weeks of March. Positive guidance and institutional coverage are possible.